Converging blockchain and next-generation AI technologies to accelerate biomedical research

(InSilico Medicine, Inc.) Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specializing in the application of deep learning for drug discovery announced the publication of the latest development of converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2hv7Q3W